Usted está aquí
Cord Blood Association
The Cord Blood Association (CBA) is a new trade and professional association for cord blood banking founded in September 2014. The CBA will be an international nonprofit organization that promotes the banking and use of umbilical cord blood and related tissues for disease treatment and regenerative therapies. Cord blood is a rich source of stem cells that can be used for restoring health in a variety of chronic diseases.
The members of the CBA will be public and private banks and individuals within and served by the cord blood community. The 13-member CBA Board of Directors has a "tripartite" membership, established in the By Laws of the new association. Four seats are for representatives of public banks, four for private/family banks, and five from the banking community at large. The at-large directors include but are not limited to research investigators, transplant clinicians, patients, parents, obstetricians, pediatricians, nurses, midwives, vendors, health policy experts or regulatory officials.
The plan for the new association, published for public comment in August, identifies five initial priorities:
 | Quality products and services - through promotion of standards and accreditation |
| Advocacy - by representing the industry nationally and internationally in matters of health care policy, legislation, regulation and public and private healthcare programs |
| Market expansion - with readily available consumer access to banking services and cellular therapies |
| Research and development - through advancement and rapid adoption of novel technologies and therapies |
| Education - with aware, informed and empowered parents, healthcare providers and general public |